Drug Type Synthetic peptide |
Synonyms- |
Target |
Mechanism CLIP1 inhibitors(CAP-Gly domain containing linker protein 1 inhibitors), PSEN1 inhibitors(Presenilin 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | 29 Dec 2021 |